Today: 3 April 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Roblox (RBLX) stock price slides today as TD Cowen flags parents limiting kids’ time

Roblox (RBLX) stock price slides today as TD Cowen flags parents limiting kids’ time

Roblox shares fell 1.5% to $72.91 Tuesday after TD Cowen reiterated a Sell rating, citing stricter parental limits on children’s playtime. Goldman Sachs maintained a Buy with a $180 target, citing AI initiatives and new partnerships. Roblox will report Q4 and full-year results on Feb. 5 after market close. The stock lagged broader tech gains as traders watched for signs of shifting user engagement.
27 January 2026
ASTS stock price rises as AST SpaceMobile’s 2026 launch pace comes back under the microscope

ASTS stock price rises as AST SpaceMobile’s 2026 launch pace comes back under the microscope

AST SpaceMobile shares rose 4.6% to $109.63 Tuesday afternoon as investors await the BlueBird 7 satellite launch, now set for late February on Blue Origin’s New Glenn rocket. Industry analysts doubt the company can meet its 2026 target of 45–60 satellites, citing slow launch progress. Pomerantz LLP launched an investor investigation. COO Shanti Gupta amended a filing to correct a 50,000-share overstatement.
27 January 2026
Adobe stock slides nearly 3% as software lags into Fed decision — what’s next for ADBE

Adobe stock slides nearly 3% as software lags into Fed decision — what’s next for ADBE

Adobe shares fell 2.7% to $296.51 Tuesday, underperforming tech peers as software stocks lagged ahead of the Federal Reserve’s policy decision and a busy earnings week. The S&P 500 hit a record, but software-focused ETFs declined, with Oracle down 4.4% and ServiceNow off 3.4%. Adobe’s next earnings report is due March 12. The Fed will announce its rate decision Wednesday.
Nebius stock price jumps nearly 8% as Nvidia-CoreWeave deal steadies AI infrastructure trade

Nebius stock price jumps nearly 8% as Nvidia-CoreWeave deal steadies AI infrastructure trade

Nebius Group N.V. shares jumped 7.6% to $98.44 Tuesday, trading on heavy volume ahead of the Federal Reserve’s rate decision. The Dutch data center operator, which recently signed major AI infrastructure deals with Microsoft and Meta, reported a $100 million loss last quarter as it spent nearly $1 billion on capital. Nebius will report earnings around Feb. 18.
ISRG stock slips after FDA clears da Vinci 5 for heart procedures; TD Cowen starts at Buy

ISRG stock slips after FDA clears da Vinci 5 for heart procedures; TD Cowen starts at Buy

Intuitive Surgical shares fell 0.7% to $525.09 Tuesday after the FDA cleared its da Vinci 5 robot for select cardiac procedures. The S&P 500 ETF rose 0.5% and QQQ gained 0.9%. TD Cowen initiated coverage with a Buy rating and $660 target, citing potential for expanded hospital adoption. Intuitive forecasts 13–15% da Vinci procedure growth in 2026, with a 1.2% revenue hit from tariffs.
Citigroup stock price edges lower after Citi banking shake-up; lawsuit and Fed decision loom

Citigroup stock price edges lower after Citi banking shake-up; lawsuit and Fed decision loom

Citigroup named Jason Rekate and John Chirico as global chairs of corporate and investment banking Tuesday, while shares slipped 0.2% to $114.63. Marcelo Marangon and Kaleem Rizvi were appointed co-heads of corporate banking, with Marangon moving to New York and Rizvi to London. A former managing director filed a lawsuit alleging sexual harassment. Traders are watching the Fed’s rate decision due Wednesday.
27 January 2026
Starbucks stock (SBUX) slips after report flags AI inventory glitches ahead of earnings

Starbucks stock (SBUX) slips after report flags AI inventory glitches ahead of earnings

Starbucks shares fell 0.7% to $95.62 Tuesday after a Reuters report cited ongoing product shortages and problems with an AI inventory tool. The drop came as the S&P 500 rose 0.5%. Starbucks will report fiscal first-quarter earnings Wednesday morning and hold its investor day Thursday. CEO Brian Niccol’s personal jet use cap was lifted after a security review, Business Insider reported.
Gilead stock hits fresh 52-week high as Wall Street lifts targets into earnings

Gilead stock hits fresh 52-week high as Wall Street lifts targets into earnings

Gilead Sciences shares rose 1.8% to $140.24 Tuesday afternoon, hitting a 12-month high of $141.69 earlier in the session. Citi, Truist, and BMO raised price targets following upbeat analyst notes and strong momentum for the company’s HIV prevention drug Yeztugo. Investors await early February results and Gilead’s earnings, expected around Feb. 10.
Arista Networks stock extends rally after Microsoft’s Maia 200 launch puts AI networking back in focus

Arista Networks stock extends rally after Microsoft’s Maia 200 launch puts AI networking back in focus

Arista Networks shares rose nearly 2% to $146.62 Tuesday, extending a 5.4% jump from the previous session and lifting its market value to about $183 billion. The gains followed Microsoft’s launch of the Maia 200 AI chip, which relies on Ethernet networking, and a bullish analyst note highlighting benefits for Arista. Investors await Microsoft’s earnings Jan. 28 and Arista’s report Feb. 12.
1 221 222 223 224 225 732

Stock Market Today

  • Exxon Mobil Stock Trends and Earnings Outlook Analysis
    April 3, 2026, 10:44 AM EDT. Exxon Mobil (XOM) recently trended on Zacks.com amid a 3.5% share decline over the past month, slightly underperforming the S&P 500's 2.8% drop and its sector's 1.1% loss. Market focus centers on earnings estimate revisions, which heavily influence stock valuation and investor sentiment. Exxon's current quarter earnings per share (EPS) are projected at $1.72, down 30.7% year-over-year, with a 4.4% negative revision in the past month. Fiscal year consensus EPS estimates stand at $7.95, down 16.5%, and next year at $7.84, showing minor declines. Zacks rates Exxon as #3 Hold, reflecting cautious investor outlook shaped by earnings and revenue growth forecasts, critical for sustained financial health and stock performance.
Go toTop